Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (251-260 of 318) with videos related to

Pageof 32
Sort By:
Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Scientific Reports|July 6, 2024
Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma modelYannik Streibel, Michael O Breckwoldt, Jessica Hunger, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Pageof 32

Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Scientific Reports|July 6, 2024
Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma modelYannik Streibel, Michael O Breckwoldt, Jessica Hunger, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Pageof 32